Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
about
A History of Cord Blood Banking and TransplantationA cord blood monocyte-derived cell therapy product accelerates brain remyelinationCell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism.The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015).
P2860
Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Preclinical characterization o ...... f inherited metabolic diseases
@nl
Preclinical characterization o ...... inherited metabolic diseases.
@ast
Preclinical characterization o ...... inherited metabolic diseases.
@en
type
label
Preclinical characterization o ...... f inherited metabolic diseases
@nl
Preclinical characterization o ...... inherited metabolic diseases.
@ast
Preclinical characterization o ...... inherited metabolic diseases.
@en
prefLabel
Preclinical characterization o ...... f inherited metabolic diseases
@nl
Preclinical characterization o ...... inherited metabolic diseases.
@ast
Preclinical characterization o ...... inherited metabolic diseases.
@en
P2093
P2860
P1433
P1476
Preclinical characterization o ...... inherited metabolic diseases.
@en
P2093
Amy Wollish
Andrew E Balber
April Ozamiz
Benjamin Rusche
David A Wenger
Joanne Kurtzberg
Pamela Noeldner
Robert W Storms
Susan Buntz
Tracy Gentry
P2860
P304
P356
10.1016/J.JCYT.2015.02.006
P407
P577
2015-03-12T00:00:00Z